Neuropsychiatric Disorders and COVID-19: What We Know So Far
Review
[키워드] addition
Admission
Affect
Angiotensin-converting enzyme 2 (ACE2)
Brain
carried
Central nervous system
Cerebrovascular disease
CNS
consequence
Consequences
COVID-19
COVID-19 patients
cranial
damaged
diagnose
events
explain
higher risk
ICU
Inflammatory response
intensive care
life-threatening
limit
literature review
manifestation
Manifestations
Mortality
nervous system
neurological
Neurological disorder
neurological manifestation
neurological problem
Neurological symptom
occur
other organs
Patient
reduce
Research
respiratory
SARS-CoV-2
Severe infection
shown
skeletal muscle injury
therapy
Treatment
vital sign
with COVID-19
[DOI] 10.3390/ph14090933 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ph14090933 PMC 바로가기 [Article Type] Review